Filter by Year:

May 9, 2024 | BIOTECHTV

Ascidian Presented NHP and Human Retinal Explant Data at #ASGCT24

April 18, 2024 | Labiotech.eu

5 RNA editing companies you should know about

February 16, 2024 | Nature

Move over, CRISPR: RNA-editing therapies pick up steam

February 12, 2024 | Endpoints

A sweeping form of search-and-replace editing has come for mRNA

February 12, 2024 | Labiotech.eu

RNA editing set to take off: could it outperform gene editing?

January 30, 2024 | BioSpace

FDA Clears Ascidian for First-Ever RNA (Exon) Editing Trial in US Read more

January 29, 2024 | BiotechTV

The Science Behind the News: Ascidian Therapeutics’ IND is cleared for an RNA exon editing program against Stargardt disease

January 29, 2024 | Ophthalmology Times

FDA approves trial plan and fast tracks Ascidian Therapeutics’ ACDN-01 in Stargardt Disease

January 29, 2024 | Endpoints

First-ever RNA editing trial in US gets clearance, pitting ‘exon editing’ technology against vision loss

January 3, 2024 | BioSpace

NextGen Class of 2024: Top Life Sciences Startups to Watch This Year